Journal of Ophthalmology

Autoimmune Diseases and the Anterior Segment of the Eye


Status
Published

Lead Editor

1University Sapienza of Rome, Rome, Italy

2Temple University, Philadelphia, USA


Autoimmune Diseases and the Anterior Segment of the Eye

Description

The anterior segment of the eye includes the ocular surface (cornea, conjunctiva, lacrimal gland, and tear film), anterior uvea (iris and ciliary body), and lens. Several ocular and systemic autoimmune diseases involve structures of the anterior segment of the eye causing conjunctivitis, keratitis, tear film dysfunction, eyelid disorders and uveitis. They represent some of the most difficult conditions to diagnose and manage in ophthalmology and often require a multidisciplinary approach. Recently, the increasing understanding of the pathogenesis of autoimmune inflammatory reaction and the development of novel drugs such as biological agents make it useful to update diagnostic protocols and the current therapeutic approaches.

Ocular autoimmune diseases include ocular cicatricial pemphigoid, Mooren’s corneal ulcer , graft versus host disease, and some forms of uveitis, including Vogt-Koyanagi-Harada syndrome, diabetes, and sympathetic ophthalmia.

Several systemic autoimmune diseases show involvement of the anterior segment of the eye including rheumatoid arthritis, systemic lupus erythematosus, Graves’ disease, Sjogren syndrome, Behcet’s disease, sarcoidosis, and ankylosing spondylitis.

We invite investigators to submit original research and review articles that will contribute to the knowledge of autoimmune diseases and ocular surface and uvea inflammatory reaction.

Potential topics include but are not limited to the following:

  • Epidemiology and clinical manifestations of autoimmune ocular diseases
  • Biomarkers of autoimmune ocular diseases
  • Diagnosis and grading of autoimmune ocular disorders including in vivo confocal microscopy, ocular surface impression cytology, and tear film function evaluation
  • Quality of life in autoimmune ocular diseases
  • Current medical and surgical treatments for autoimmune ocular diseases (including steroids, immunosuppressive drugs, biological agents, and amniotic membrane transplantation)

Articles

  • Special Issue
  • - Volume 2018
  • - Article ID 6029460
  • - Editorial

Autoimmune Diseases and the Anterior Segment of the Eye

Marta Sacchetti | Flavio Mantelli | Alessandro Lambiase
  • Special Issue
  • - Volume 2018
  • - Article ID 1061276
  • - Research Article

Tear Ferning Test and Pathological Effects on Ocular Surface before and after Topical Cyclosporine in Vernal Keratoconjunctivitis Patients

Marcella Nebbioso | Marta Sacchetti | ... | Alessandro Lambiase
  • Special Issue
  • - Volume 2018
  • - Article ID 8372146
  • - Research Article

Long-Term Follow-Up after Intravenous Immunoglobulin Therapy in Patients with Severe Ocular Mucous Membrane Pemphigoid Unresponsive to Conventional Therapy

Stefania Leuci | Massimo Amato | ... | Michele Davide Mignogna
  • Special Issue
  • - Volume 2018
  • - Article ID 3850172
  • - Research Article

Vascular Endothelial Growth Factor (VEGF) Serological and Lacrimal Signaling in Patients Affected by Vernal Keratoconjunctivitis (VKC)

Marcella Nebbioso | Andrea Iannaccone | ... | Anna Maria Zicari
  • Special Issue
  • - Volume 2018
  • - Article ID 2401213
  • - Research Article

Evaluation of Reliability and Validity of Three Common Dry Eye Questionnaires in Chinese

Fan Lu | Aizhu Tao | ... | Ping Lu
  • Special Issue
  • - Volume 2018
  • - Article ID 6430953
  • - Research Article

Manifestation of Clinical Categories of Ocular Graft-versus-Host Disease

Yuan Qiu | Jing Hong | Rongmei Peng
  • Special Issue
  • - Volume 2018
  • - Article ID 9136017
  • - Research Article

The Evolution of Central Retinal and Choroidal Thickness in Acute Anterior Uveitic Patients with Spondyloarthropathy

Zsuzsanna Szepessy | Árpád Barsi | ... | Zoltán Zsolt Nagy
Journal of Ophthalmology
 Journal metrics
Acceptance rate36%
Submission to final decision74 days
Acceptance to publication31 days
CiteScore2.800
Impact Factor1.447
 Submit